Literature DB >> 15099518

Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3.

Andrei Kuzmichev1, Thomas Jenuwein, Paul Tempst, Danny Reinberg.   

Abstract

Human Enhancer of Zeste homolog (Ezh2) is a histone lysine methyltransferase (HKMT) associated with transcriptional repression. Ezh2 is present in several distinct complexes, one of which, PRC2, we characterized previously. Here we report an additional Ezh2 complex, PRC3. We show that the Ezh2 complexes exhibit differential targeting of specific histones for lysine methylation dependent upon the context of the histone substrates. This differential targeting is a function of the associated Eed protein within each complex. We found that Eed protein is present in four isoforms, which represent alternate translation start site usage from the same mRNA. These Eed isoforms selectively associate with distinct Ezh2-containing complexes with resultant differential targeting of their associated HKMT activity toward histone H3-K27 or histone H1-K26. Our data provide evidence for a novel mechanism regulating the substrate specificity of a chromatin-modifying enzyme through disparate translational products of a regulatory subunit.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099518     DOI: 10.1016/s1097-2765(04)00185-6

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  175 in total

1.  Epigenetic modification of histone 3 lysine 27: mediator subunit MED25 is required for the dissociation of polycomb repressive complex 2 from the promoter of cytochrome P450 2C9.

Authors:  Neal A Englert; George Luo; Joyce A Goldstein; Sailesh Surapureddi
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

2.  Structural analysis of the core COMPASS family of histone H3K4 methylases from yeast to human.

Authors:  Yoh-hei Takahashi; Gerwin H Westfield; Austin N Oleskie; Raymond C Trievel; Ali Shilatifard; Georgios Skiniotis
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-07       Impact factor: 11.205

3.  Regulation by polycomb and trithorax group proteins in Arabidopsis.

Authors:  Raúl Alvarez-Venegas
Journal:  Arabidopsis Book       Date:  2010-05-08

4.  Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.

Authors:  Damian B Yap; Justin Chu; Tobias Berg; Matthieu Schapira; S-W Grace Cheng; Annie Moradian; Ryan D Morin; Andrew J Mungall; Barbara Meissner; Merrill Boyle; Victor E Marquez; Marco A Marra; Randy D Gascoyne; R Keith Humphries; Cheryl H Arrowsmith; Gregg B Morin; Samuel A J R Aparicio
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

5.  Uncovering the human methyltransferasome.

Authors:  Tanya C Petrossian; Steven G Clarke
Journal:  Mol Cell Proteomics       Date:  2010-10-07       Impact factor: 5.911

6.  Distinct Cellular Assembly Stoichiometry of Polycomb Complexes on Chromatin Revealed by Single-molecule Chromatin Immunoprecipitation Imaging.

Authors:  Roubina Tatavosian; Chao Yu Zhen; Huy Nguyen Duc; Maggie M Balas; Aaron M Johnson; Xiaojun Ren
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

7.  EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway.

Authors:  Te Liu; Lengchen Hou; Yongyi Huang
Journal:  Tumour Biol       Date:  2014-04-27

8.  Loss of RBBP4 results in defective inner cell mass, severe apoptosis, hyperacetylated histones and preimplantation lethality in mice†.

Authors:  Xiaosu Miao; Tieqi Sun; Holly Barletta; Jesse Mager; Wei Cui
Journal:  Biol Reprod       Date:  2020-06-23       Impact factor: 4.285

9.  Molecular and functional mapping of EED motifs required for PRC2-dependent histone methylation.

Authors:  Nathan D Montgomery; Della Yee; Stephanie A Montgomery; Terry Magnuson
Journal:  J Mol Biol       Date:  2007-10-22       Impact factor: 5.469

Review 10.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.